vs

Side-by-side financial comparison of LSB INDUSTRIES, INC. (LXU) and PHOTRONICS INC (PLAB). Click either name above to swap in a different company.

PHOTRONICS INC is the larger business by last-quarter revenue ($210.4M vs $169.5M, roughly 1.2× LSB INDUSTRIES, INC.). LSB INDUSTRIES, INC. runs the higher net margin — 11.6% vs 10.9%, a 0.7% gap on every dollar of revenue. On growth, LSB INDUSTRIES, INC. posted the faster year-over-year revenue change (18.2% vs -5.5%). Over the past eight quarters, LSB INDUSTRIES, INC.'s revenue compounded faster (10.0% CAGR vs -3.8%).

Eldridge Industries, LLC is an American holding company headquartered in Miami, with offices in New York City, Greenwich, Connecticut, London, and Beverly Hills. It invests in industries such as insurance, asset management, technology, sports, media, real estate, and the consumer sector.

Photronics, Inc. is an American semiconductor photomask manufacturer. It was the third largest photomask supplier globally as of 2009. Photronics is a member of the eBeam Initiative.

LXU vs PLAB — Head-to-Head

Bigger by revenue
PLAB
PLAB
1.2× larger
PLAB
$210.4M
$169.5M
LXU
Growing faster (revenue YoY)
LXU
LXU
+23.7% gap
LXU
18.2%
-5.5%
PLAB
Higher net margin
LXU
LXU
0.7% more per $
LXU
11.6%
10.9%
PLAB
Faster 2-yr revenue CAGR
LXU
LXU
Annualised
LXU
10.0%
-3.8%
PLAB

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
LXU
LXU
PLAB
PLAB
Revenue
$169.5M
$210.4M
Net Profit
$19.7M
$22.9M
Gross Margin
21.1%
33.7%
Operating Margin
13.7%
22.9%
Net Margin
11.6%
10.9%
Revenue YoY
18.2%
-5.5%
Net Profit YoY
-32.4%
EPS (diluted)
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LXU
LXU
PLAB
PLAB
Q1 26
$169.5M
Q4 25
$165.0M
Q3 25
$155.4M
$210.4M
Q2 25
$151.3M
$211.0M
Q1 25
$143.4M
$212.1M
Q4 24
$134.9M
$222.6M
Q3 24
$109.2M
$211.0M
Q2 24
$140.1M
$217.0M
Net Profit
LXU
LXU
PLAB
PLAB
Q1 26
$19.7M
Q4 25
$16.1M
Q3 25
$7.1M
$22.9M
Q2 25
$3.0M
$8.9M
Q1 25
$-1.6M
$42.9M
Q4 24
$-9.1M
$33.9M
Q3 24
$-25.4M
$34.4M
Q2 24
$9.6M
$36.3M
Gross Margin
LXU
LXU
PLAB
PLAB
Q1 26
21.1%
Q4 25
25.0%
Q3 25
16.4%
33.7%
Q2 25
15.3%
36.9%
Q1 25
10.0%
35.6%
Q4 24
4.5%
37.0%
Q3 24
-7.3%
35.6%
Q2 24
19.6%
36.5%
Operating Margin
LXU
LXU
PLAB
PLAB
Q1 26
13.7%
Q4 25
16.2%
Q3 25
10.1%
22.9%
Q2 25
6.9%
26.4%
Q1 25
3.1%
24.6%
Q4 24
-5.0%
25.1%
Q3 24
-22.4%
24.7%
Q2 24
10.3%
25.8%
Net Margin
LXU
LXU
PLAB
PLAB
Q1 26
11.6%
Q4 25
9.8%
Q3 25
4.6%
10.9%
Q2 25
2.0%
4.2%
Q1 25
-1.1%
20.2%
Q4 24
-6.8%
15.2%
Q3 24
-23.2%
16.3%
Q2 24
6.8%
16.7%
EPS (diluted)
LXU
LXU
PLAB
PLAB
Q1 26
Q4 25
$0.22
Q3 25
$0.10
$0.39
Q2 25
$0.04
$0.15
Q1 25
$-0.02
$0.68
Q4 24
$-0.13
$0.54
Q3 24
$-0.35
$0.55
Q2 24
$0.13
$0.58

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LXU
LXU
PLAB
PLAB
Cash + ST InvestmentsLiquidity on hand
$181.7M
$575.8M
Total DebtLower is stronger
$770.0K
$16.0K
Stockholders' EquityBook value
$542.9M
$1.1B
Total Assets
$1.2B
$1.8B
Debt / EquityLower = less leverage
0.00×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LXU
LXU
PLAB
PLAB
Q1 26
$181.7M
Q4 25
$148.5M
Q3 25
$152.0M
$575.8M
Q2 25
$124.9M
$558.4M
Q1 25
$163.5M
$642.2M
Q4 24
$184.2M
$640.7M
Q3 24
$199.3M
$606.4M
Q2 24
$216.3M
$559.9M
Total Debt
LXU
LXU
PLAB
PLAB
Q1 26
$770.0K
Q4 25
$440.3M
Q3 25
$447.6M
$16.0K
Q2 25
$446.4M
$19.0K
Q1 25
$478.2M
$21.0K
Q4 24
$476.2M
$25.0K
Q3 24
$476.0M
$28.0K
Q2 24
$479.8M
$2.5M
Stockholders' Equity
LXU
LXU
PLAB
PLAB
Q1 26
$542.9M
Q4 25
$520.0M
Q3 25
$504.6M
$1.1B
Q2 25
$495.8M
$1.1B
Q1 25
$490.6M
$1.1B
Q4 24
$491.6M
$1.1B
Q3 24
$499.0M
$1.1B
Q2 24
$522.8M
$1.0B
Total Assets
LXU
LXU
PLAB
PLAB
Q1 26
$1.2B
Q4 25
$1.2B
Q3 25
$1.1B
$1.8B
Q2 25
$1.1B
$1.7B
Q1 25
$1.2B
$1.7B
Q4 24
$1.2B
$1.7B
Q3 24
$1.2B
$1.6B
Q2 24
$1.2B
$1.6B
Debt / Equity
LXU
LXU
PLAB
PLAB
Q1 26
0.00×
Q4 25
0.85×
Q3 25
0.89×
0.00×
Q2 25
0.90×
0.00×
Q1 25
0.97×
0.00×
Q4 24
0.97×
0.00×
Q3 24
0.95×
0.00×
Q2 24
0.92×
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LXU
LXU
PLAB
PLAB
Operating Cash FlowLast quarter
$50.1M
Free Cash FlowOCF − Capex
$25.2M
FCF MarginFCF / Revenue
12.0%
Capex IntensityCapex / Revenue
11.8%
Cash ConversionOCF / Net Profit
2.19×
TTM Free Cash FlowTrailing 4 quarters
$64.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LXU
LXU
PLAB
PLAB
Q1 26
Q4 25
$17.9M
Q3 25
$52.6M
$50.1M
Q2 25
$18.2M
$31.5M
Q1 25
$6.8M
$78.5M
Q4 24
$4.0M
$68.4M
Q3 24
$17.1M
$75.1M
Q2 24
$41.4M
$76.5M
Free Cash Flow
LXU
LXU
PLAB
PLAB
Q1 26
Q4 25
$-3.2M
Q3 25
$35.6M
$25.2M
Q2 25
$-315.0K
$-29.1M
Q1 25
$-14.0M
$43.3M
Q4 24
$-24.2M
$25.2M
Q3 24
$-13.9M
$50.7M
Q2 24
$26.6M
$56.5M
FCF Margin
LXU
LXU
PLAB
PLAB
Q1 26
Q4 25
-1.9%
Q3 25
22.9%
12.0%
Q2 25
-0.2%
-13.8%
Q1 25
-9.8%
20.4%
Q4 24
-18.0%
11.3%
Q3 24
-12.8%
24.0%
Q2 24
19.0%
26.0%
Capex Intensity
LXU
LXU
PLAB
PLAB
Q1 26
Q4 25
12.8%
Q3 25
10.9%
11.8%
Q2 25
12.2%
28.7%
Q1 25
14.5%
16.6%
Q4 24
20.9%
19.4%
Q3 24
28.4%
11.6%
Q2 24
10.5%
9.2%
Cash Conversion
LXU
LXU
PLAB
PLAB
Q1 26
Q4 25
1.11×
Q3 25
7.39×
2.19×
Q2 25
6.04×
3.55×
Q1 25
1.83×
Q4 24
2.02×
Q3 24
2.18×
Q2 24
4.33×
2.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LXU
LXU

AN & Nitric Acid$75.3M44%
Urea ammonium nitrate (UAN)$49.2M29%
Ammonia$36.8M22%
Other$8.2M5%

PLAB
PLAB

High End Integrated Circuits$53.6M25%
High End Flat Panel Displays$53.5M25%
KR$43.7M21%
Other$42.1M20%
Mainstream Flat Panel Displays$9.1M4%
Transferred At Point In Time$8.4M4%

Related Comparisons